Pharmaceutical Industry Information Portal

HomeNews

News

Bavarian Nordic starts share buy-back program

Bavarian Nordic A/S May 9th announced the initiation of a new share buy-back program, under which the Company intends to buy back up to...

FDA lifts ban on LogicBio’s clinical trial on pediatric patients with methylmalonic acidemia

LogicBio Therapeutics, Inc., a clinical-stage company advancing a diversified pipeline of genetic medicines addressing rare disorders from infancy through adulthood, May 9th announced that...

AbbVie and Cerebras collaborate to accelerate artificial intelligence biopharmaceutical research

Cerebras Systems, the pioneer in high performance artificial intelligence (AI) computing, and AbbVie, a global biopharmaceutical company, announced a landmark achievement in AbbVie’s AI...

Takeda Pharmaceutical expected fourth-quarter net income to decline

Takeda is expected to post a 92% drop in net profit from a year earlier to 15.96 billion yen ($122.3 million) for the quarter...

Lupin receives two FDA approvals and share price jumps

Global pharma major Lupin Ltd, May 06th, announced that it has received approval from the United States Food and Drug Administration (FDA) for its...

Clovis Oncology shares plummeted this week

Following the release of its first-quarter results and operational update, Clovis Oncology's shares traded down sharply. According to data provided by S&P Global Market...
spot_img

Expert Articles

spot_img